Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artículo científico |
| Sprache: | en |
| Veröffentlicht: |
EMBO reports
2025
|
| Schlagworte: | |
| Online-Zugang: | https://pubmed.ncbi.nlm.nih.gov/39747664/ |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Inhaltsangabe:
- E3 ligase FBXW7 suppresses brown fat expansion and browning of white fat. Yu, Jian Gu, Xuejiang Guo, Yingying Gao, Mingyuan Cheng, Shimiao Meng, Meiyao Cui, Xiangdi Zhang, Zhe Guo, Wenxiu Yan, Dandan Sheng, Maozheng Zhai, Linhui Ji, Jing Ma, Xinhui Li, Yu Cao, Yuxiang Wu, Xia Zhao, Jiejie Hu, Yepeng Tan, Minjia Lu, Yan Xu, Lingyan Liu, Bin Hu, Cheng Ma, Xinran F-Box-WD Repeat-Containing Protein 7 Animals Adipose Tissue, Brown Mice Adipose Tissue, White Thermogenesis Energy Metabolism Obesity Male Ubiquitination Humans Mice, Inbred C57BL Diet, High-Fat Thermogenic fat, including brown and beige fat, dissipates heat via thermogenesis and enhances energy expenditure. Thus, its activation represents a therapeutic strategy to combat obesity. Here, we demonstrate that levels of F-box and WD repeat domain-containing 7 (FBXW7), an E3 ubiquitin protein ligase, negatively correlate with thermogenic fat functionality. FBXW7 overexpression in fat suppresses energy expenditure and thermogenesis, thus aggravates obesity and metabolic dysfunctions in mice. Conversely, FBXW7 depletion in fat leads to brown fat expansion and browning of white fat, and protects mice from diet induced obesity, hepatic steatosis, and hyperlipidemia. Mechanistically, FBXW7 binds to S6K1 and promotes its ubiquitination and proteasomal degradation, which in turn impacts glycolysis and brown preadipocyte proliferation via lactate. Besides, the beneficial metabolic effects of FBXW7 depletion in fat are attenuated by fat-specific knockdown of S6K1 in vivo. In summary, we provide evidence that adipose FBXW7 acts as a major regulator for thermogenic fat biology and energy homeostasis and serves as potential therapeutic target for obesity and metabolic diseases.